Artikel mit Open-Access-Mandaten - Sudheer Kumar GaraWeitere Informationen
Nicht verfügbar: 1
Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma
D Patel, R Ellis, B Howard, M Boufraqech, SK Gara, L Zhang, ...
Annals of surgical oncology 21, 3541-3547, 2014
Mandate: US National Institutes of Health
Verfügbar: 30
Three novel collagen VI chains with high homology to the α3 chain
SK Gara, P Grumati, A Urciuolo, P Bonaldo, B Kobbe, M Koch, ...
Journal of Biological Chemistry 283 (16), 10658-10670, 2008
Mandate: Deutsche Forschungsgemeinschaft
TGF-β signaling in myeloid cells is required for tumor metastasis
Y Pang, SK Gara, BR Achyut, Z Li, HH Yan, CP Day, JM Weiss, ...
Cancer discovery 3 (8), 936-951, 2013
Mandate: US National Institutes of Health
Germline HABP2 mutation causing familial nonmedullary thyroid cancer
SK Gara, L Jia, MJ Merino, SK Agarwal, L Zhang, M Cam, D Patel, ...
New England Journal of Medicine 373 (5), 448-455, 2015
Mandate: US National Institutes of Health
Expression of the collagen VI α5 and α6 chains in normal human skin and in skin of patients with collagen VI-related myopathies
P Sabatelli, SK Gara, P Grumati, A Urciuolo, F Gualandi, R Curci, ...
Journal of Investigative Dermatology 131 (1), 99-107, 2011
Mandate: Deutsche Forschungsgemeinschaft, Fondazione Telethon, Italy
Expression of collagen VI α5 and α6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis
P Sabatelli, F Gualandi, SK Gara, P Grumati, A Zamparelli, E Martoni, ...
Matrix Biology 31 (3), 187-196, 2012
Mandate: Deutsche Forschungsgemeinschaft, Fondazione Telethon, Italy
miR30a inhibits LOX expression and anaplastic thyroid cancer progression
M Boufraqech, N Nilubol, L Zhang, SK Gara, SM Sadowski, A Mehta, ...
Cancer research 75 (2), 367-377, 2015
Mandate: US National Institutes of Health
Gr‐1+ CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression
Z Li, Y Pang, SK Gara, BR Achyut, C Heger, PK Goldsmith, S Lonning, ...
International journal of cancer 131 (11), 2584-2595, 2012
Mandate: US National Institutes of Health
Differential and restricted expression of novel collagen VI chains in mouse
SK Gara, P Grumati, S Squarzoni, P Sabatelli, A Urciuolo, P Bonaldo, ...
Matrix Biology 30 (4), 248-257, 2011
Mandate: US National Institutes of Health, Deutsche Forschungsgemeinschaft
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
SK Gara, J Lack, L Zhang, E Harris, M Cam, E Kebebew
Nature Communications 9 (1), 4172, 2018
Mandate: US National Institutes of Health
Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 inhibits thyroid cancer growth and metastases
S Kotian, L Zhang, M Boufraqech, K Gaskins, SK Gara, M Quezado, ...
Clinical Cancer Research 23 (17), 5044-5054, 2017
Mandate: US National Institutes of Health
RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma
Y Liu-Chittenden, M Jain, K Gaskins, S Wang, MJ Merino, S Kotian, ...
Oncogene 36 (25), 3541-3552, 2017
Mandate: US National Institutes of Health
The knee osteoarthritis susceptibility locus DVWA on chromosome 3p24. 3 is the 5′ part of the split COL6A4 gene
R Wagener, SK Gara, B Kobbe, M Paulsson, F Zaucke
Matrix Biology 28 (6), 307-310, 2009
Mandate: Deutsche Forschungsgemeinschaft
Distinct genome‐wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors
A Tirosh, S Mukherjee, J Lack, SK Gara, S Wang, MM Quezado, ...
Cancer 125 (8), 1247-1257, 2019
Mandate: US National Institutes of Health
A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16
TC Pan, RZ Zhang, M Arita, S Bogdanovich, SM Adams, SK Gara, ...
Journal of Biological Chemistry 289 (15), 10293-10307, 2014
Mandate: US National Institutes of Health, Deutsche Forschungsgemeinschaft
Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples
SK Gara, Y Wang, D Patel, Y Liu-Chittenden, M Jain, M Boufraqech, ...
Nucleic Acids Research 43 (19), 9327-9339, 2015
Mandate: US National Institutes of Health
Lysyl oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness
M Boufraqech, D Patel, N Nilubol, A Powers, T King, J Shell, J Lack, ...
Thyroid 29 (1), 79-92, 2019
Mandate: US National Institutes of Health
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response
N Nilubol, M Boufraqech, L Zhang, K Gaskins, M Shen, YQ Zhang, ...
Oncotarget 9 (68), 33030, 2018
Mandate: US National Institutes of Health
Phase I trial of systemic intravenous infusion of interleukin‐13‐Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma
Y Liu‐Chittenden, M Jain, P Kumar, D Patel, R Aufforth, V Neychev, ...
Cancer medicine 4 (7), 1060-1068, 2015
Mandate: US National Institutes of Health
UHRF1 is a novel druggable epigenetic target in malignant pleural mesothelioma
ES Reardon, V Shukla, S Xi, SK Gara, Y Liu, D Straughan, M Zhang, ...
Journal of Thoracic Oncology 16 (1), 89-103, 2021
Mandate: US National Institutes of Health
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt